Combined [qlco]
Hormone replacement therapy [topp]
Endothelial [tisu]
function [phsf]
Health [idcn]
postmenopausal [tmco]
Women [popg]
objectives [inpr]
Large [qnco]
Scale [medd]
Epidemiological Studies [resa]
Suggest [idcn]
Hormone replacement therapy [topp]
cardiovascular events [fndg]
postmenopausal [tmco]
Women [popg]
Improvement [cnce]
Endothelial [tisu]
function [phsf]
Contribute [acty]
Design [acty]
prospective [resa]
Double-Blind Study [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
randomized [resa]
Receive [qlco]
Oral [spco]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Estradiol 2 MG [clnd]
norethindrone acetate 1 MG [clnd]
placebo [topp]
Endothelial [tisu]
function [phsf]
Assessed [acty]
Flow [npop]
mediated [socb]
Vasodilation [phsf]
FMD [cgab, dsyn]
Brachial Artery [bpoc]
soluble [celc]
ENDOTHELIAL CELL ADHESION MOLECULE [gngm]
Before [tmco]
months [tmco]
therapy [ftcn]
FMD [cgab, dsyn]
Improved [qlco]
Women [popg]
Combined [qlco]
Hormone replacement therapy [topp]
3 Months [tmco]
months [tmco]
P NOS [aapp, imft]
baseline [bodm]
Values [qlco]
placebo [topp]
Group [idcn]
baseline [bodm]
months [tmco]
3 Months [tmco]
Combined [qlco]
Hormone replacement therapy [topp]
decreases [qnco]
E-Selectin [aapp, imft, rcpt]
Intercellular adhesion molecule 1 [aapp, imft]
Observed [ftcn]
P NOS [aapp, imft]
baseline [bodm]
Values [qlco]
Sustained [ftcn]
months [tmco]
therapy [ftcn]
placebo [topp]
Group [idcn]
Conclusions [idcn]
Estradiol [horm, phsu, strd]
Norethisterone acetate [horm, phsu, strd]
Endothelial [tisu]
function [phsf]
Enhance [acty]
FMD [cgab, dsyn]
Reducing [qlco]
Levels [qlco]
soluble [celc]
Selectin [aapp, bacs]
Intercellular adhesion molecule 1 [aapp, imft]
Health [idcn]
postmenopausal [tmco]
Women [popg]
